Background:
The hypothesized link between the measles, mumps, rubella (MMR) vaccine and autism continues to cause concern and challenge vaccine uptake.
Objective:
To evaluate whether the MMR vaccine increases the risk for autism in children, subgroups of children, or time periods after vaccination.
Design:
Nationwide cohort study.
Setting:
Denmark.
Participants:
657 461 children born in Denmark from 1999 through 31 December 2010, with follow-up from 1 year of age and through 31 August 2013.
Measurements:
Danish population registries were used to link information on MMR vaccination, autism diagnoses, other childhood vaccines, sibling history of autism, and autism risk factors to children in the cohort. Survival analysis of the time to autism diagnosis with Cox proportional hazards regression was used to estimate hazard ratios of autism according to MMR vaccination status, with adjustment for age, birth year, sex, other childhood vaccines, sibling history of autism, and autism risk factors (based on a disease risk score).
Results:
During 5 025 754 person-years of follow-up, 6517 children were diagnosed with autism (incidence rate, 129.7 per 100 000 person-years). Comparing MMR-vaccinated with MMR-unvaccinated children yielded a fully adjusted autism hazard ratio of 0.93 (95% CI, 0.85 to 1.02). Similarly, no increased risk for autism after MMR vaccination was consistently observed in subgroups of children defined according to sibling history of autism, autism risk factors (based on a disease risk score) or other childhood vaccinations, or during specified time periods after vaccination.
Limitation:
No individual medical charts were reviewed.
Conclusion:
The study strongly supports that MMR vaccination does not increase the risk for autism, does not trigger autism in susceptible children, and is not associated with clustering of autism cases after vaccination. It adds to previous studies through significant additional statistical power and by addressing hypotheses of susceptible subgroups and clustering of cases.
Primary Funding Source:
Novo Nordisk Foundation and Danish Ministry of Health.
References
- 1.
Wakefield A ,Murch S ,Anthony A ,Linnell J ,Casson D ,Malik M ,et al . RETRACTED: Ileal-lymphoid-nodular hyperplasia, nonspecific colitis, and pervasive developmental disorder in children. Lancet. 1998;351:637-41. CrossrefMedlineGoogle Scholar - 2.
Taylor LE ,Swerdfeger AL , andEslick GD . Vaccines are not associated with autism: An evidence-based meta-analysis of case-control and cohort studies. Vaccine. 2014;32:3623-9. CrossrefMedlineGoogle Scholar - 3.
Jain A ,Marshall J ,Buikema A ,Bancroft T ,Kelly JP , andNewschaffer CJ . Autism occurrence by MMR vaccine status among US children with older siblings with and without autism. JAMA. 2015;313:1534-40. CrossrefMedlineGoogle Scholar - 4.
Uno Y ,Uchiyama T ,Kurosawa M ,Aleksic B , andOzaki N . Early exposure to the combined measles-mumps-rubella vaccine and thimerosal-containing vaccines and risk for autism spectrum disorder. Vaccine. 2015;33:2511-6. CrossrefMedlineGoogle Scholar - 5.
Madsen KM ,Hviid A ,Vestergaard M ,Schendel D ,Wohlfahrt J ,Thorsen P ,et al . A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med. 2002;347:1477-82. CrossrefMedlineGoogle Scholar - 6.
Spitzer WO . Measles, mumps, and rubella vaccination and autism. N Engl J Med. 2003;348:951-4. CrossrefMedlineGoogle Scholar - 7.
Fombonne E andChakrabarti S . No evidence for a new variant of measles-mumps-rubella-induced autism. Pediatrics. 2001;108:E58. CrossrefMedlineGoogle Scholar - 8.
Pedersen CB . The Danish Civil Registration System. Scand J Public Health. 2011;39:22-5. CrossrefMedlineGoogle Scholar - 9.
Andersen JS ,De Fine Olivarius N , andKrasnik A . The Danish National Health Service Register. Scand J Public Health. 2011;39:34-7. CrossrefMedlineGoogle Scholar - 10.
Mors O ,Perto GP , andMortensen PB . The Danish Psychiatric Central Research Register. Scand J Public Health. 2011;39:54-7. CrossrefMedlineGoogle Scholar - 11.
Lynge E ,Sandegaard JL , andRebolj M . The Danish National Patient Register. Scand J Public Health. 2011;39:30-3. CrossrefMedlineGoogle Scholar - 12.
Modabbernia A ,Velthorst E , andReichenberg A . Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses. Mol Autism. 2017;8:13. CrossrefMedlineGoogle Scholar - 13.
Knudsen LB andOlsen J . The Danish Medical Birth Registry. Dan Med Bull. 1998;45:320-3. MedlineGoogle Scholar - 14.
McCullagh P andNelder JA . Generalized Linear Models. New York Chapman and Hall 1989 419-31. Google Scholar - 15.
Tadrous M ,Gagne JJ ,Stürmer T , andCadarette SM . Disease risk score as a confounder summary method: systematic review and recommendations. Pharmacoepidemiol Drug Saf. 2013;22:122-9. CrossrefMedlineGoogle Scholar - 16. The PHREG procedure. In: SAS/STAT 13.2 User's Guide. Accessed at http://support.sas.com/documentation/cdl/en/statug/67523/HTML/default/viewer.htm#statug_phreg_details32.htm on 19 February 2019. Google Scholar
- 17.
Mrozek-Budzyn D ,Kiełtyka A , andMajewska R . Lack of association between measles-mumps-rubella vaccination and autism in children. Pediatr Infect Dis J. 2010;29:397-400. CrossrefMedlineGoogle Scholar - 18.
Uno Y ,Uchiyama T ,Kurosawa M ,Aleksic B , andOzaki N . The combined measles, mumps, and rubella vaccines and the total number of vaccines are not associated with development of autism spectrum disorder: the first case-control study in Asia. Vaccine. 2012;30:4292-8. CrossrefMedlineGoogle Scholar - 19.
Smeeth L ,Cook C ,Fombonne E ,Heavey L ,Rodrigues LC ,Smith PG ,et al . MMR vaccination and pervasive developmental disorders: a case-control study. Lancet. 2004;364:963-9. CrossrefMedlineGoogle Scholar - 20.
DeStefano F ,Bhasin TK ,Thompson WW ,Yeargin-Allsopp M , andBoyle C . Age at first measles-mumps-rubella vaccination in children with autism and school-matched control subjects: a population-based study in metropolitan Atlanta. Pediatrics. 2004;113:259-66. CrossrefMedlineGoogle Scholar - 21.
Glickman G ,Harrison E , andDobkins K . Vaccination rates among younger siblings of children with autism. N Engl J Med. 2017;377:1099-101. CrossrefMedlineGoogle Scholar - 22.
Taylor B ,Miller E ,Lingam R ,Andrews N ,Simmons A , andStowe J . Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. BMJ. 2002;324:393-6. CrossrefMedlineGoogle Scholar - 23.
Eslick GD . Answers regarding the link between vaccines and the development of autism: A question of appropriate study design, ethics, and bias. Vaccine. 2015;33:5497. CrossrefMedlineGoogle Scholar - 24.
Elsabbagh M ,Divan G ,Koh YJ ,Kim YS ,Kauchali S ,Marcín C ,et al . Global prevalence of autism and other pervasive developmental disorders. Autism Res. 2012;5:160-79. CrossrefMedlineGoogle Scholar - 25.
Lyall K ,Croen L ,Daniels J ,Fallin MD ,Ladd-Acosta C ,Lee BK ,et al . The changing epidemiology of autism spectrum disorders. Annu Rev Public Health. 2017;38:81-102. CrossrefMedlineGoogle Scholar - 26.
Filia A ,Bella A ,Del Manso M ,Baggieri M ,Magurano F , andRota MC . Ongoing outbreak with well over 4,000 measles cases in Italy from January to end August 2017—what is making elimination so difficult? Euro Surveill. 2017;22:30614. CrossrefMedlineGoogle Scholar - 27.
Lo NC andHotez PJ . Public health and economic consequences of vaccine hesitancy for measles in the United States. JAMA Pediatr. 2017;171:887-92. CrossrefMedlineGoogle Scholar - 28.
Poland GA andJacobson RM . The age-old struggle against the antivaccinationists. N Engl J Med. 2011;364:97-9. CrossrefMedlineGoogle Scholar
Author, Article and Disclosure Information
Financial Support: By the Novo Nordisk Foundation and the Danish Ministry of Health.
Disclosures: Dr. Hviid reports grants from Novo Nordisk Foundation during the conduct of the study. Dr. Hansen reports grants from Novo Nordisk Foundation during the conduct of the study. Authors not named here have disclosed no conflicts of interest. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M18-2101.
Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that her spouse has stock options/holdings with Targeted Diagnostics and Therapeutics. Darren B. Taichman, MD, PhD, Executive Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Catharine B. Stack, PhD, MS, Deputy Editor for Statistics, reports that she has stock holdings in Pfizer, Johnson & Johnson, and Colgate-Palmolive. Christina C. Wee, MD, MPH, Deputy Editor, reports employment with Beth Israel Deaconess Medical Center. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Yu-Xiao Yang, MD, MSCE, Deputy Editor, reports that he has no financial relationships or interest to disclose.
Reproducible Research Statement:Study protocol, statistical code, and data set: Not available.
Corresponding Author: Anders Hviid, DrMedSci, Department of Epidemiology Research, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark; e-mail, [email protected].
Current Author Addresses: Drs. Hviid, Hansen, Frisch, and Melbye: Department of Epidemiology Research, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark.
Author Contributions: Conception and design: A. Hviid, M. Melbye, J. Vinsløv Hansen.
Analysis and interpretation of the data: A. Hviid, M. Melbye, J. Vinsløv Hansen.
Drafting of the article: A. Hviid.
Critical revision for important intellectual content: M. Frisch, M. Melbye, J. Vinsløv Hansen.
Final approval of the article: M. Frisch, A. Hviid, M. Melbye, J. Vinsløv Hansen.
Provision of study materials or patients: M. Frisch.
Statistical expertise: J. Vinsløv Hansen.
Obtaining of funding: A. Hviid.
Administrative, technical, or logistic support: M. Frisch, M. Melbye.
This article was published at Annals.org on 5 March 2019.
Submit a Comment
Contributors must reveal any conflict of interest. Comments are moderated.